Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index

All categories

DBCAT003988Pharmacologic class

A DrugBank category of 25 drugs. 20 of them are approved.

Part of: Drugs that are Mainly Renally Excreted
Also known as: Drugs that are Mainly Renally Excreted with Narrow Therapeutic Index
Drugs: Amikacin
Arbekacin
Bekanamycin
Capreomycin
Cisplatin
Colistin
Dibekacin
Digoxin
Gentamicin
Gentamicin C1a
Isepamicin
Kanamycin
Lithium carbonate
Micronomicin
Nedaplatin
Netilmicin
Pemetrexed
Pentostatin
Plazomicin
Procainamide
Ribostamycin
Sisomicin
Streptomycin
Tobramycin
Vancomycin

What you can answer from here — as of November 04, 2020

25DrugsEach linked to its full drug card

Listed above

48Drug targetsEvery drug–target pair in the class, with bond type

3,653Marketed productsAcross the regions we cover, with dosage forms and routes

23Routes of administrationHow the drugs in this class are given

Which targets do Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account